P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Accounts Payable Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Accounts Payable
â‚©10.2B
CAGR 3-Years
77%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Accounts Payable
â‚©50.9B
CAGR 3-Years
30%
CAGR 5-Years
4%
CAGR 10-Years
31%
SK Bioscience Co Ltd
KRX:302440
Accounts Payable
â‚©3.4B
CAGR 3-Years
-42%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Accounts Payable
â‚©2.5B
CAGR 3-Years
-15%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Accounts Payable
â‚©1.7B
CAGR 3-Years
24%
CAGR 5-Years
26%
CAGR 10-Years
3%
Alteogen Inc
KOSDAQ:196170
Accounts Payable
â‚©824.7m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Accounts Payable?
Accounts Payable
10.2B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Accounts Payable amounts to 10.2B KRW.

What is PharmaResearch Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
20%

Over the last year, the Accounts Payable growth was 27%. The average annual Accounts Payable growth rates for PharmaResearch Co Ltd have been 77% over the past three years , 20% over the past five years .

Back to Top